Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04006236 · ClinicalTrials.gov registry record · NA

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

A NA study of Infant Development, sponsored by Abbott Nutrition.

Completed
Registry status
NA
Development phase
245
Enrollment target
17
Study locations

NCT04006236 is a NA study of Infant Development that has completed, run by Abbott Nutrition. The registered enrollment target is 245 participants, below the 395-participant average among 30 other Infant Development trials with a reported enrollment target (38% lower). The trial reports 17 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04006236, a NA study of Infant Development, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
NA
Development phase
245 participants
Enrollment target
17
Study locations

Study Summary

This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.

Conditions Studied

Interventions

  • OTHER Experimental Infant Formula
  • OTHER Control Infant Formula

Study Locations (17)

Ohio

  • Pediatric Associates of Fairfield, Inc. - Fairfield
  • Institute of Clinical Research, LLC - Mentor
  • The Cleveland Pediatric Research Center, LLC - Middleburg Heights

Texas

  • Ventavia Research Group, Llc - Fort Worth
  • Ventavia Research Group - Houston
  • Ventavia Research Group, LLC - Plano

Arizona

  • MedPharmics, LLC - Phoenix
  • Watching Over Mothers & Babies - Tucson

Georgia

  • Paramount Research Solutions - College Park

Kentucky

  • Springs Medical Research - Owensboro

Louisiana

  • MedPharmics, LLC - Metairie

Mississippi

  • MedPharmics, LLC - Gulfport

Nebraska

  • Quality Clinical Research Inc - Omaha

Trial Details

FieldValue
Enrollment Target 245 participants
Start Date 2019-08-05
Est. Completion 2021-09-20
Phase NA

Sponsor

Abbott Nutrition

89 total trials

What the Registry Record Tells You About NCT04006236

The ClinicalTrials.gov registry entry for NCT04006236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 395-participant average among 30 other Infant Development trials with a reported enrollment target (38% lower). The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infant Development appearing as the primary indexed condition, and to 2 interventions - of which Experimental Infant Formula is the first listed.

NCT04006236 reports 17 study locations spanning 12 distinct geographic areas - top geographies include Ohio, Texas, Arizona.

Frequently Asked Questions

What is clinical trial NCT04006236 about?

NCT04006236 is a clinical study titled "Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas". This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.

What is the current status of trial NCT04006236?

This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2019-08-05. Estimated completion is 2021-09-20.

What conditions does trial NCT04006236 study?

This clinical trial studies the following conditions: Infant Development.

What interventions are being tested in trial NCT04006236?

The interventions under investigation include: Experimental Infant Formula (OTHER), Control Infant Formula (OTHER).

Who is sponsoring clinical trial NCT04006236?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04006236 being conducted?

This trial has 17 study locations across Arizona, Georgia, Kentucky, Louisiana, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.